J&J accepts $2.1 billion bid for its LifeScan diabetes business
June 12, 2018 at 16:30 PM EDT
The $2.1 billion offer is from private equity firm Platinum Equity.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|